Ken Griffin Pro Mis Neurosciences Inc. Call Options Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMN
# of Institutions
25Shares Held
10MCall Options Held
0Put Options Held
0-
Ally Bridge Group (Ny) LLC New York, NY6.23MShares$2.43 Million2.7% of portfolio
-
Armistice Capital, LLC New York, NY2.97MShares$1.16 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3295KShares$115,1220.03% of portfolio
-
Hrt Financial LP New York, NY68.1KShares$26,5420.0% of portfolio
-
Xtx Topco LTD London, X067.7KShares$26,3970.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...